WILMINGTON, Mass., June 1, 2015 /PRNewswire/ -- Implant
Sciences Corporation (OTCQB: IMSC), a leading manufacturer of
explosives trace detection (ETD) and drugs trace detection
solutions for homeland security applications, today announced that
it has signed an exclusive distribution agreement, worth up to
$5 million, with Ryan Security
Technologies Ltd. to manage sales and service of its products
throughout all of China.
"We are thrilled to partner with Ryan Security to build on and
grow our market reach in China,"
said Dr. Darryl Jones, Vice
President of Global Sales and Marketing. "Ryan has a great
reputation and track record of success, which we believe will
enable our partnership to leverage the momentum of our ETD
technology adoption in the US and Europe to help drive sales in China."
"We believe that Implant Sciences' systems represent the best
and most advanced ETD system on the market," said Eric Ryan, President of Ryan Security
Technologies. "We are excited to represent Implant Sciences
in China. Their ETD systems and
capabilities bring best-in-class security technology to the
demanding Chinese market and to meet the needs of security
operators."
"China has and will continue to
be a large and important market for our company and technology,"
added Dr. William McGann, Chief
Executive Officer of Implant Sciences Corporation. "We are
very excited about the partnership with Ryan and about our
company's future in the Chinese security market as we seek to win
sales and grow our global footprint."
About Implant Sciences
Implant Sciences is a leader in developing and manufacturing
advanced detection capabilities to counter and eliminate the
ever-evolving threats from explosives and drugs. The Company's team
of dedicated trace detection experts has developed proprietary
technologies used in its commercial products, thousands of which
have been sold across more than 60 countries worldwide. The
Company's ETDs have received approvals and certifications from
several international regulatory agencies including the TSA in the
U.S., ECAC in Europe, CAAC and the
Ministry of Public Safety in China, Russia FSB, STAC in France, and the German Ministry of the
Interior. It has also received the GSN Homeland Security Award for
"Best Explosives Detection Solution" two years in a row (2013 and
2014). All Implant Sciences products are recognized as
Qualified Anti-Terrorism Technologies by the Department of Homeland
Security. For further details on the Company and its products,
please visit the Company's website at www.implantsciences.com.
Cautionary Note Regarding Forward-Looking Statements
This press release and any statements of employees,
representatives and partners of Implant Sciences Corporation (the
"Company") related thereto contain or may contain certain
"forward-looking statements," as that term is defined in the
Private Securities Litigation Reform Act of 1995. Such
statements may include, without limitation, statements with respect
to the Company's plans, objectives, projections, expectations and
intentions and other statements identified by words such as
"projects," "may," "will," "could," "would," "should," "believes,"
"expects," "anticipates," "estimates," "intends," "plans,"
"potential," "seeks" or similar expressions. Such statements
are based on management's current expectations and are subject to
significant risks and uncertainties (many of which are beyond the
Company's control) that could cause the Company's actual results to
differ materially from the forward-looking statements. Such
risks and uncertainties include, but are not limited to, the risks
that there is no guaranty that the Transportation Security
Administration (TSA) or any other U.S. or foreign government and
law enforcement agencies or commercial consumers (including in
China) will purchase any of our
explosives detection products or that any new products we may
develop will be accepted by the TSA or by such other governments,
agencies or consumers; economic, political and other risks
associated with international sales and operations could adversely
affect our sales; our business is subject to intense competition
and rapid technological change, and our ability to generate revenue
and profit will depend on our ability to develop and introduce new
products; and other risks and uncertainties described in our
filings with the Securities and Exchange Commission, including our
most recent Forms 10-K, 10-Q and 8-K. In light of these risks
and uncertainties, readers are cautioned that actual results may
differ significantly from those described or anticipated in the
forward-looking statements. The Company undertakes no
obligation to publicly update any forward-looking statements,
whether as a result of new information, future presentations or
otherwise, except as required by applicable law.
Contact:
Implant Sciences Corporation
Company Contact:
Robert Liscouski
978-752-1700 x 116
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/implant-sciences-signs-deal-for-up-to-5-million-with-ryan-security-technologies-ltd-to-expand-sales-in-china-300091136.html
SOURCE Implant Sciences Corporation